Title of article
Living donor liver transplantation: where do we stand and where are we going?
Author/Authors
lu, hao nanjing medical university - liver transplantation center, first affiliated hospital, Nanjing, China , lu, ling nanjing medical university - liver transplantation center, first affiliated hospital, Nanjing, China , zhang, feng nanjing medical university - liver transplantation center, first affiliated hospital, Nanjing, China , zhai, yuan nanjing medical university - liver transplantation center, first affiliated hospital, Nanjing, China , wang, xuehao nanjing medical university - liver transplantation center, first affiliated hospital, Nanjing, China
From page
141
To page
144
Abstract
Liver transplantation (LT) remains a lifesaving therapy for patients with end-stage liver disease, but the shortage of graft donor (deceased donor) limits development of LT. Living donor liver transplantation (LDLT) is the only alternative to deceased donor liver transplantation (DDLT), but LDLT requires more sophisticated surgical techniques. In addition, LDLT does not have the advantage in their survival in response to immunosuppressive therapies. In this paper, we reviewed recent development of LDLT in China mainland, especially surgical technique and immune therapy.
Keywords
Living donor liver transplantation (LDLT) , small , for , size syndrome (SFSS) , immune therapy , regulatory T cells (Tregs)
Journal title
Hepatobiliary Surgery and Nutrition
Journal title
Hepatobiliary Surgery and Nutrition
Record number
2654152
Link To Document